Is light transmittance aggregometry still a useful tool to assess pharmacodynamic effects of antiplatelet therapy?

Paul A. Gurbel; Martin G. Gesheff; Christopher J. Franzese; Kevin P. Bliden; Udaya S. Tantry

doi:10.3109/09537104.2014.920497

Is light transmittance aggregometry still a useful tool to assess pharmacodynamic effects of antiplatelet therapy?

Paul A. Gurbel, Martin G. Gesheff, Christopher J. Franzese, Kevin P. Bliden, Udaya S. Tantry

School of Medicine

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	608-609
Number of pages	2
Journal	Platelets
Volume	26
Issue number	6
DOIs	https://doi.org/10.3109/09537104.2014.920497
State	Published - Aug 18 2015

Keywords

Antiplatelet therapy
light transmittance aggregometry
platelet function testing

ASJC Scopus subject areas

Hematology

Access to Document

10.3109/09537104.2014.920497

Cite this

@article{3ad34d877e014f6e8ddd76093ea6d4e4,

title = "Is light transmittance aggregometry still a useful tool to assess pharmacodynamic effects of antiplatelet therapy?",

keywords = "Antiplatelet therapy, light transmittance aggregometry, platelet function testing",

author = "Gurbel, {Paul A.} and Gesheff, {Martin G.} and Franzese, {Christopher J.} and Bliden, {Kevin P.} and Tantry, {Udaya S.}",

year = "2015",

month = aug,

day = "18",

doi = "10.3109/09537104.2014.920497",

language = "English (US)",

volume = "26",

pages = "608--609",

journal = "Platelets",

issn = "0953-7104",